Section Arrow
OPK.NASDAQ
- OPKO Health
Quotes are at least 15-min delayed:2024/05/18 20:45 EDT
Last
 1.32
+0.02 (+1.54%)
Day High 
1.36 
Prev. Close
1.3 
1-M High
1.36 
Volume 
2.82M 
Bid
1.31
Ask
1.34
Day Low
1.265 
Open
1.3 
1-M Low
1.15 
Market Cap 
906.09M 
Currency USD 
P/E -- 
%Yield
10-SMA 1.29 
20-SMA 1.27 
50-SMA 1.18 
52-W High 2.24 
52-W Low 0.8516 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.35/-0.28
Enterprise Value
1.19B
Balance Sheet
Book Value Per Share
1.80
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
863.50M
Operating Revenue Per Share
1.24
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DHRDanaher Corp265.8+0.96+0.36%48.59PE
LABStandard BioTools2.57+0.07+2.80%-- 
OPKOPKO Health1.32+0.02+1.54%-- 
GHGuardant Health25.36-0.88-3.35%-- 
EXASExact Sciences Corp50.38-1.57-3.02%-- 
Quotes are at least 15-min delayed:2024/05/18 20:45 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.